JARDIANCE (empagliflozin) - Renal and Urology News

JARDIANCE (empagliflozin)

Slideshow

  • jardiance-empagliflozin-diabetes-mellitus-drug-101

  • jardiance-empagliflozin-diabetes-mellitus-drug-211

  • jardiance-empagliflozin-diabetes-mellitus-drug-321

  • jardiance-empagliflozin-diabetes-mellitus-drug-431

  • jardiance-empagliflozin-diabetes-mellitus-drug-541

  • jardiance-empagliflozin-diabetes-mellitus-drug-651

  • jardiance-empagliflozin-diabetes-mellitus-drug-761

  • jardiance-empagliflozin-diabetes-mellitus-drug-871

  • jardiance-empagliflozin-diabetes-mellitus-drug-981

  • jardiance-empagliflozin-diabetes-mellitus-drug-109

  • jardiance-empagliflozin-diabetes-mellitus-drug-111

  • jardiance-empagliflozin-diabetes-mellitus-drug-121

  • jardiance-empagliflozin-diabetes-mellitus-drug-131

  • jardiance-empagliflozin-diabetes-mellitus-drug-141

  • jardiance-empagliflozin-diabetes-mellitus-drug-151

  • jardiance-empagliflozin-diabetes-mellitus-drug-161

This slideshow reviews drug information for JARDIANCE (empagliflozin) indicated for the treatment of type 2 diabetes mellitus.

Table of Contents

Slide 3: Indication, Dosage & Administration
Slide 6: Use in Specific Populations
Slide 8: Clinical Pharmacology
Slide 11: Warnings & Precautions
Slide 14: Drug Storage & Supply

Next hm-slideshow in Slides